LifeMD (LFMD) Expected to Announce Quarterly Earnings on Monday

LifeMD (NASDAQ:LFMD) is anticipated to announce its earnings results after the market closes on Monday, March 10th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $57.43 million for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

LifeMD Price Performance

Shares of LFMD opened at $4.67 on Friday. The company has a market capitalization of $202.27 million, a price-to-earnings ratio of -7.30 and a beta of 1.50. The business’s 50-day moving average is $5.66 and its 200-day moving average is $5.38. LifeMD has a fifty-two week low of $3.99 and a fifty-two week high of $12.88.

Wall Street Analyst Weigh In

A number of research firms have issued reports on LFMD. KeyCorp cut their target price on shares of LifeMD from $10.00 to $7.00 and set an “overweight” rating for the company in a research report on Wednesday, January 8th. Mizuho began coverage on shares of LifeMD in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $7.00 target price for the company. HC Wainwright reiterated a “buy” rating and issued a $12.00 target price on shares of LifeMD in a research report on Monday, November 11th. Finally, Lake Street Capital began coverage on shares of LifeMD in a research report on Tuesday, December 10th. They issued a “buy” rating and a $12.00 target price for the company. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $11.14.

Insider Activity

In other news, CEO Justin Schreiber sold 50,000 shares of the firm’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $7.55, for a total transaction of $377,500.00. Following the transaction, the chief executive officer now owns 2,653,715 shares in the company, valued at approximately $20,035,548.25. This trade represents a 1.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 15.97% of the stock is owned by insiders.

About LifeMD

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.